Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
196,028
-
Share change
-
-30,505,175
-
Total reported value
-
$474,000
-
Price per share
-
$2.41
-
Number of holders
-
2
-
Value change
-
-$19,545,506
-
Number of sells
-
46
Institutional Holders of NABRIVA THERAPEUTICS PLC - SHS as of Q4 2020
As of 31 Dec 2020,
NABRIVA THERAPEUTICS PLC - SHS was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
196,028 shares.
The largest 2 holders included
Aisling Capital Management LP and Sterling Investment Advisors, Ltd..
This page lists
2
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.